UVA Research Leads to New Drug for Deadliest Blood Cancer
12/3/2025
Biomedical research that began at the University of Virginia School of Medicine has yielded a much-needed new treatment for patients with the deadliest form of blood cancer. The federal Food…
Research in Motion: Gordon Laurie, PhD
12/3/2025
There are no effective treatments for many chronic diseases. One approach is an unbiased screen. We did this to address the most common eye disease and discovered a new protein…
Blood-Pressure Discovery Could Open Door to New Hypertension Treatments
12/3/2025
University of Virginia School of Medicine scientists have obtained important new insights into how our bodies regulate our blood pressure by revealing how our cells turn off a key hormone.…
11/18/2025
Breast cancer survivors are more likely to experience insomnia and depression than people in the general population. This is a serious problem because these two conditions often feed into each…
Research in Motion: Zhenqi Liu, MD
11/18/2025
I'm a clinical endocrinologist treating patients with a variety of hormonal disorders, including diabetes. My laboratory is focused on how insulin works in the body, including vasculature and skeletal muscle,…
1st Death Linked to ‘Meat Allergy’ Spread by Ticks
11/18/2025
University of Virginia School of Medicine researchers have identified the first death caused by what is commonly called the “meat allergy” being spread by ticks. A healthy 47-year-old man from…
UVA Division of Perceptual Studies Publishes Two New Papers in Psychiatric Times
11/11/2025
Researchers at the University of Virginia’s Division of Perceptual Studies (DOPS) bring national attention to the role of extraordinary experiences and spirituality in psychiatry through two new publications in Psychiatric…
Analysis Reveals Return on Investment From NIH Funding
11/11/2025
New University of Virginia School of Medicine research highlights how National Institutes of Health research grants are instrumental in nurturing scientific discoveries by young medical trainees. But the findings also…
